8 results
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Prophylaxis: • CD4 ... count <50 cells ... Mycobacterium #AviumComplex ... #MAC #IDSA #Prevention
Acute Kidney Injury - AKI Workup Algorithm and Differential Diagnosis
Baseline Investigations: full blood count with differential,
Kidney Injury - AKI ... Workup Algorithm ... Investigations: full blood count ... Anti-ds-DNA, C3/C4 ... #Workup #Algorithm
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... Prophylaxis: • CD4 ... count <150 cells ... count ≥150 cells ... Histoplasmosis #IDSA
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Patients with CD4 ... Count <200/mm3) ... times weekly (AI ... count >200 cells
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... positive serology and CD4 ... count <250 cells ... mg/kg IV daily (AII ... Coccidiodomycosis #IDSA
IDSA Recommendations for Treating Bartonella Infections in HIV-AIDS
Preferred Therapy
For Bacillary Angiomatosis, Peliosis Hepatis, Bacteremia, and Osteomyelitis:
IDSA Recommendations ... PO or IV q12h (AII ... as long as the CD4 ... count remains < ... Bartonellosis #IDSA
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... patients with CD4 ... count ≥200 cells ... 500 mg PO TID (AII ... #Zoster #VZV #IDSA
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... • Since low CD4 ... cell count and ... [visceral KS (AI ... KaposiSarcoma #Castlemans #IDSA